22/03/21
Cumulus Oncology launches partnership with Lead Discovery Center GmbH – an exciting next chapter for this pioneering Eos portfolio company
04/03/21
ClinSpec Diagnostics Limited (ClinSpec Dx) reaches its round two funding target of £3.5 million from Norcliffe Capital Limited, the University of Strathclyde, Eos Advisory and the founders.
17/02/21
Eos portfolio Cumulus Oncology eyes further growth as US office is set to open this year
05/01/21
‘Lab on a chip’ technology company RAB Microfluidics completes £1.24 million investment round lead by Eos Advisory
01/12/20
ILC Therapeutics announces significant and first international investor Medical Incubator Japan (MIJ) in a round that includes further investment from Eos
25/11/20
Edinburgh based Cumulus Oncology appoints Nicola Broughton, Chris Brinsmead, Mohamed Raza (Raz) Dewji and Ian Waddell to their advisory board
15/09/20
Eos portfolio business ClinSpec DX focused on the early detection of cancer has received a major seven-figure funding injection
15/09/20
Eos portfolio business ClinSpec DX secures a further £2.4m in Funding for Early Cancer Detection Tech
15/09/20
Eos portfolio business, the cancer drug discovery accelerator Cumulus Oncology, launches its first spinout – Modulus Oncology
